ScholarIQanswers from OpenAlex & ORCID
David O. Taylor
ResearcherPublications, citations & collaboration network
David O. Taylor is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David O. Taylor have?
ScholarIQindexed works
David O. Taylor has 298 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David O. Taylor have?
ScholarIQcitation count
David O. Taylor has 18,584 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David O. Taylor?
ScholarIQh-index
David O. Taylor has an h-index of 65 in OpenAlex.
What is the i10-index of David O. Taylor?
ScholarIQi10-index
David O. Taylor has an i10-index of 142 in OpenAlex.
What is the ORCID of David O. Taylor?
ScholarIQorcid
The ORCID for David O. Taylor is on the source record.
What is the OpenAlex record for David O. Taylor?
ScholarIQopenalex
The OpenAlex for David O. Taylor is on the source record.
What are the most-cited papers on David O. Taylor?
ScholarIQmost cited works
Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure
Wilfried Müllens, Zuheir Abrahams, Gary S. Francis, George Sokos, David O. Taylor, Randall C. Starling, James B. Young, W.H. Wilson Tang
The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update
Mandeep R. Mehra, Charles E. Canter, Margaret M. Hannan, Marc J. Semigran, Patricia A. Uber, David A. Baran, Lara Danziger‐Isakov, James K. Kirklin, Richard Kirk, Sudhir S. Kushwaha, Lars H. Lund, Luciano Potena, Heather J. Ross, David O. Taylor, Erik A.M. Verschuuren, Andreas Zuckermann
Consensus Conference Report
Jonathan G. Zaroff, Bruce R. Rosengard, William F. Armstrong, Wayne D. Babcock, Anthony M. D’Alessandro, G. William Dec, Niloo M. Edwards, Robert Higgins, Valluvan Jeevanandum, Myron Kauffman, James K. Kirklin, Stephen Large, Daniel Marelli, T. Peterson, W. Steves Ring, Robert C. Robbins, Stuart D. Russell, David O. Taylor, Adrian Van Bakel, J. Wallwork, James B. Young
A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus11This study was sponsored by a grant from Fujisawa USA, Deerfield, Illinois.22The authors were working on behalf of the Tacrolimus US Heart Transplant Multicenter Study Group. Other members of the Study Group included (principal investigator listed first): UTAH Cardiac Transplant Program, Salt Lake City, Utah: David O. Taylor, MD, Dale G. Renlund, MD, Abdallah G. Kfoury, MD; St. Luke’s Episcopal Hospital/Texas Heart Institute, Houston, Texas: O. H. Frazier, MD, Branislav Radovancevic, MD, Edward K. Massin, MD; University of Wisconsin Hospitals and Clinics, Madison, Wisconsin: Robert M. Mentzer, Jr., MD, Charles C. Canver, MD, Robert B. Love, MD; Ochsner Medical Foundation, New Orleans, Louisiana: Frank W. Smart, MD, Hector O. Ventura, MD, Dwight D. Stapleton, MD, Mandeep Mehra, MD; University of Southern California, Los Angeles, California: Mark L. Barr, MD, Vaugh A. Starnes, MD; Medical College of Virginia, Richmond, Virginia: David E. Tolman, MD, Albert Guerraty, MD, David Salter, MD; Cleveland Clinic Foundation, Cleveland, Ohio: James B. Young, MD; Data Management and Statistical Coordinating Center-The EMMES Corporation, Potomac, Maryland: Paul VanVeldhuisen, MS, Anne Lindblad, PhD, Anita Yaffe, MSN, MPH.
David O. Taylor, Mark L. Barr, Branislav Radovančević, Dale G. Renlund, Robert M. Mentzer, Frank W. Smart, David Tolman, O.H. Frazier, James B. Young, Paul VanVeldhuisen